rethinkTHC Search
Menu
Study breakdown

Activating Brain CB1 Receptors Changed Blood Pressure and Breathing in Rats

evidence
The takeaway

CB1 receptor activation in the brainstem of anesthetized rats increased sympathetic nerve activity and blood pressure while abolishing phrenic nerve activity that drives breathing.

What the researchers found

Researchers activated CB1 cannabinoid receptors in a specific brainstem region called the rostral ventrolateral medulla oblongata (RVLM) of anesthetized rats. This region is critical for controlling both cardiovascular function and breathing.

CB1 activation produced dose-dependent increases in sympathetic nerve activity and blood pressure. Strikingly, it also completely abolished phrenic nerve activity, the nerve output responsible for driving diaphragm contractions during breathing.

This was the first demonstration that cannabinoid receptors in this particular brainstem region could simultaneously affect both cardiovascular and respiratory control, suggesting a previously unknown mechanism through which cannabinoids might influence vital autonomic functions.

Why it matters

The brainstem regions controlling blood pressure and breathing are fundamental to survival. Discovering that CB1 receptors in this area can dramatically alter both systems provided a new mechanism to investigate regarding cannabinoid effects on cardiovascular and respiratory function, including potential risks.

The numbers in context

CB1 activation produced dose-dependent increases in sympathetic nerve activity and blood pressure. Phrenic nerve activity was completely abolished. Effects were localized to the rostral ventrolateral medulla oblongata.

How the study worked

Researchers used anesthetized rats and directly applied a CB1 receptor agonist to the rostral ventrolateral medulla oblongata via microinjection. They simultaneously recorded sympathetic nerve activity, blood pressure, and phrenic nerve discharge to measure dose-dependent cardiorespiratory effects.

What this study cannot tell us

This was an acute animal study using direct brain microinjection in anesthetized rats, which does not replicate how cannabinoids reach the brain during normal cannabis use. Anesthesia itself affects autonomic function. The doses and delivery method have no direct human equivalent.

How to read the evidence

An animal mechanistic study using direct brain drug delivery, providing initial evidence of a CB1-cardiorespiratory pathway that requires further investigation.

The bigger picture

This study expanded understanding of where in the brain cannabinoids act to influence vital functions. The finding that a single brainstem region links cannabinoid signaling to both heart and lung control has implications for understanding rare but serious cardiovascular and respiratory events associated with cannabis use.

Common questions

Does smoking cannabis affect breathing through this mechanism?
This study injected a drug directly into a brainstem region in anesthetized rats. Whether inhaled cannabis activates CB1 receptors in this specific area at sufficient concentrations to produce similar effects in humans is unknown.
Why did blood pressure go up instead of down?
CB1 activation in this brainstem region increased sympathetic nerve outflow, which raises blood pressure. This is specific to this brain area and differs from the blood pressure-lowering effects cannabinoids can produce through other mechanisms.

Read the original research

Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats.

British journal of pharmacology, 140(2), 384-94

Citation

Padley, James R; Li, Qun; Pilowsky, Paul M; Goodchild, Ann K. (2003). Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats.. British journal of pharmacology, 140(2), 384-94.